A Placebo-Controlled, Dose-Escalating Study to Examine the Safety and Tolerability of Single Intravenous Doses of CF-301 in Healthy Subjects

Clinical trial NCT02439359 · COMPLETED

Trial details

NCT number: NCT02439359
Sponsor: ContraFect
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Staphylococcus Aureus Bloodstream Infections (BSI; Bacteremia)

Start date: 2015-05-01
Primary completion: 2015-12-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.